Mr. Guido Moll, PhD, Dipl Ing - Karolinska Institutet

Mr. Guido Moll

PhD, Dipl Ing

Karolinska Institutet

Stockholm | Sweden

Mr. Guido Moll, PhD, Dipl Ing - Karolinska Institutet

Mr. Guido Moll

PhD, Dipl Ing

Introduction

Primary Affiliation: Karolinska Institutet - Stockholm , Sweden

Publications

8Publications

174Reads

6Profile Views

224PubMed Central Citations

Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?

PLoS One 2014 13;9(1):e85040. Epub 2014 Jan 13.

Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden ; Hematology Center, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085040PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890285PMC
September 2014
10 Reads
11 Citations
3.234 Impact Factor

Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation.

Stem Cells 2013 Aug;31(8):1715-25

Department of Medicine, Karolinska Institutet, Hematology Center, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.1386DOI Listing
August 2013
29 Reads
15 Citations
6.523 Impact Factor

Viability and proliferation of rat MSCs on adhesion protein-modified PET and PU scaffolds.

Biomaterials 2012 Nov 16;33(32):8094-103. Epub 2012 Aug 16.

Advanced Center for Translational Regenerative Medicine (ACTREM), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2012.07.060DOI Listing
November 2012
68 Reads
4 Citations
8.560 Impact Factor

Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.

Tissue Eng Part B Rev 2012 Apr 22;18(2):101-15. Epub 2011 Dec 22.

Department of Tissue Regeneration, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/ten.TEB.2011.0488DOI Listing
April 2012
7 Reads
52 Citations

Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study.

Lancet 2011 12 24;378(9808):1997-2004. Epub 2011 Nov 24.

Advanced Center for Translational Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden; European Airway Institute, Karolinska Institutet, Stockholm, Sweden; Division of Ear, Nose and Throat, Karolinska University Hospital, Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(11)61715-7DOI Listing
December 2011
26 Reads
82 Citations
45.220 Impact Factor

Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses.

PLoS One 2011 1;6(7):e21703. Epub 2011 Jul 1.

Department of Laboratory Medicine, Clinical Immunology and Transfusion Medicine, Karolinska Institutet and Hematology Center at Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0021703PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128611PMC
November 2011
16 Reads
19 Citations
3.234 Impact Factor

Crimean-Congo hemorrhagic fever virus activates endothelial cells.

J Virol 2011 Aug 1;85(15):7766-74. Epub 2011 Jun 1.

KCB/Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.02469-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147921PMC
August 2011
9 Reads
11 Citations
4.440 Impact Factor

Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

Blood 2007 Aug 16;110(4):1326-9. Epub 2007 Apr 16.

Australian Centre for Vaccine Development, Tumor Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-01-066100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939905PMC
August 2007
9 Reads
30 Citations
10.452 Impact Factor